NASDAQ:PFMT • US71377E1055
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PERFORMANT HEALTHCARE INC (PFMT).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-11-07 | B. Riley Securities | Maintains | Buy -> Buy |
| 2024-07-25 | B. Riley Securities | Initiate | Buy |
| 2021-07-07 | Craig-Hallum | Initiate | Buy |
| 2021-06-04 | Colliers Securities | Initiate | Buy |
| 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 124.4M -20.21% | 109.2M -12.22% | 113.743M 4.16% | 124.8M 9.72% | 137.16M 9.90% | |
| EBITDA YoY % growth | 6.69M -63.28% | -2.08M -131.09% | -595K 71.39% | 4.329M 827.56% | 10.201M 135.64% | |
| EBIT YoY % growth | 1.5M -88.46% | -6.6M -540.00% | -5.782M 12.39% | -9.792M -69.36% | -4.272M 56.37% | |
| Operating Margin | 1.21% | -6.04% | -5.08% | -7.85% | -3.11% | |
| EPS YoY % growth | -0.11 -164.71% | -0.08 27.27% | -0.10 -25.00% | -0.14 -39.40% | -0.07 51.22% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.02 -185.02% | -0.05 4.79% | -0.02 40.51% | -0.01 77.32% | 0.01 179.96% |
| Revenue Q2Q % growth | 34.83M 6.95% | 29.729M 8.76% | 32.673M 11.28% | 35.375M 12.23% | 39.388M 13.09% |
| EBITDA Q2Q % growth | 3.052M -57.61% | -279.48K 87.22% | 1.83M 192.33% | 3.348M -0.74% | 5.235M 71.53% |
| EBIT Q2Q % growth | -64.597K -103.21% | -3.719M -3.74% | -1.186M 55.94% | -193.8K 89.64% | 1.438M 2,326.12% |
All data in USD
9 analysts have analysed PFMT and the average price target is 7.14 USD. This implies a price increase of 100.56% is expected in the next year compared to the current price of 3.56.
The consensus EPS estimate for the next earnings of PERFORMANT HEALTHCARE INC (PFMT) is -0.02 USD and the consensus revenue estimate is 34.83M USD.